María Isolina
Santiago Pérez
Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (6)
2024
-
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol
Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1
-
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study
The Lancet Infectious Diseases, Vol. 24, Núm. 8, pp. 817-828
-
Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study
Pediatric Allergy and Immunology, Vol. 35, Núm. 5
2023
-
Mortality Attributable to Environmental Tobacco Smoke Exposure in Spain in 2020
Archivos de Bronconeumologia, Vol. 59, Núm. 5, pp. 305-310
2022
-
Methodological guidelines for the estimation of attributable mortality using a prevalence-based method: the STREAMS-P tool
Journal of Clinical Epidemiology, Vol. 147, pp. 101-110
-
Serum cotinine cut-points for secondhand smoke exposure assessment in children under 5 years: A systemic review
PLoS ONE, Vol. 17, Núm. 5 May